Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A well differentiated, low grade neuroendocrine tumor (carcinoid tumor) that arises from the small intestine. The mitotic count is less than 2 per 10 HPF and/or the Ki67 index is equal to or less than 2 percent.
Biomarker and diagnostic research for small intestinal neuroendocrine tumor G1 has been reported in the published literature.
1 clinical trial registered, 1 recruiting. Interventions under study include medical devices. Pipeline includes 1 NA. Research is primarily sponsored by academic and government institutions.
57 publications have been identified in PubMed for small intestinal neuroendocrine tumor G1. Research spans Case Report / Case Series (32%), Diagnostic / Biomarker (19%), and Review / Meta-Analysis (16%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 18 |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 4:41 PM UTC
Testing and diagnosis research | 11 | 19% |
Research summaries | 9 | 16% |
Clinical study results | 8 | 14% |
Disease patterns and progression | 8 | 14% |
Laboratory research | 2 | 4% |
New treatment approaches | 1 | 2% |
Shinkubo N (2026). [PMID: 42098036](https://pubmed.ncbi.nlm.nih.gov/42098036/). *Gan To Kagaku Ryoho*. [Case Report / Case Series]
Ammann M (2026). [PMID: 41184714](https://pubmed.ncbi.nlm.nih.gov/41184714/). *Ann Surg Oncol*. [Epidemiology / Natural History]
Ammann M (2026). [PMID: 41042466](https://pubmed.ncbi.nlm.nih.gov/41042466/). *Ann Surg Oncol*. [Clinical Trial Publication]
Sawma T (2026). [PMID: 40751721](https://pubmed.ncbi.nlm.nih.gov/40751721/). *Mayo Clin Proc*. [Clinical Trial Publication]
Ergenç M (2026). [PMID: 41998800](https://pubmed.ncbi.nlm.nih.gov/41998800/). *Cancer Control*. [Diagnostic / Biomarker]
Papantoniou D (2026). [PMID: 42108725](https://pubmed.ncbi.nlm.nih.gov/42108725/). *J Neuroendocrinol*. [Diagnostic / Biomarker]
Ocasio Quinones GA (2026). [PMID: 32809560](https://pubmed.ncbi.nlm.nih.gov/32809560/). *Unknown Journal*. [Review / Meta-Analysis]
Byer SH (2026). [PMID: 41608071](https://pubmed.ncbi.nlm.nih.gov/41608071/). *Eur Heart J Case Rep*. [Case Report / Case Series]
Rahmatullah ZF (2026). [PMID: 41663800](https://pubmed.ncbi.nlm.nih.gov/41663800/). *Emerg Radiol*. [Epidemiology / Natural History]
Alnajar A (2026). [PMID: 41277750](https://pubmed.ncbi.nlm.nih.gov/41277750/). *J Surg Oncol*. [Epidemiology / Natural History]